Gouni-Berthold, Ioanna
Schwarz, Jonas
Article History
Accepted: 23 March 2022
First Online: 22 April 2022
Declarations
:
: I. Gouni-Berthold has received personal honoraria for consulting from Amgen, Regeneron, Aegereon, Akcea Therapeutics, Daiichi-Sankyo, Novartis, Pfizer, Sanofi and Amarin. J. Schwarz declares that he has no competing interests.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.